ATE173925T1 - Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen - Google Patents
Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformenInfo
- Publication number
- ATE173925T1 ATE173925T1 AT93923156T AT93923156T ATE173925T1 AT E173925 T1 ATE173925 T1 AT E173925T1 AT 93923156 T AT93923156 T AT 93923156T AT 93923156 T AT93923156 T AT 93923156T AT E173925 T1 ATE173925 T1 AT E173925T1
- Authority
- AT
- Austria
- Prior art keywords
- calcium lactate
- quinoloonecarbonic
- irritative
- administration
- soluble calcium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/966,998 US5290794A (en) | 1992-10-27 | 1992-10-27 | Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE173925T1 true ATE173925T1 (de) | 1998-12-15 |
Family
ID=25512170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93923156T ATE173925T1 (de) | 1992-10-27 | 1993-09-29 | Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen |
Country Status (13)
Country | Link |
---|---|
US (1) | US5290794A (de) |
EP (1) | EP0666743B1 (de) |
JP (1) | JPH08504190A (de) |
AT (1) | ATE173925T1 (de) |
AU (1) | AU670838B2 (de) |
CA (1) | CA2144652A1 (de) |
DE (1) | DE69322405T2 (de) |
DK (1) | DK0666743T3 (de) |
ES (1) | ES2124797T3 (de) |
MX (1) | MX9306321A (de) |
NZ (1) | NZ256962A (de) |
SG (1) | SG46482A1 (de) |
WO (1) | WO1994009779A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602254A (en) * | 1995-05-26 | 1997-02-11 | Warner-Lambert Company | Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form |
ID21415A (id) | 1997-12-05 | 1999-06-10 | Upjohn Co | Senyawa-senyawa antibiotik magnesium quinolon |
MX2007000336A (es) * | 2004-07-02 | 2007-03-28 | Daiichi Seiyaku Co | Composicion medicinal que contiene quinolona. |
CA2693473A1 (en) * | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of pkb |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
DE3508816A1 (de) * | 1985-01-10 | 1986-07-10 | Bayer Ag, 5090 Leverkusen | 6,7-disubstituierte 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3-carbonsaeuren |
US4771054A (en) * | 1985-01-23 | 1988-09-13 | Warner-Lambert Company | Antibacterial agents |
DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
AU594983B2 (en) * | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
DE3713672A1 (de) * | 1987-04-24 | 1988-11-17 | Bayer Ag | Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren |
US4851418A (en) * | 1987-08-21 | 1989-07-25 | Warner-Lambert Company | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent |
US4929613A (en) * | 1987-08-26 | 1990-05-29 | Warner-Lambert Company | Antibacterial agents |
DE3831514A1 (de) * | 1988-09-16 | 1990-03-22 | Bayer Ag | Ph-neutrale waessrige loesungen von chinoloncarbonsaeuren |
US5057520A (en) * | 1989-03-24 | 1991-10-15 | Abbott Laboratories | 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds |
US4916141A (en) * | 1989-03-28 | 1990-04-10 | Warner-Lambert Company | (S)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid |
NZ232740A (en) * | 1989-04-20 | 1992-06-25 | Riker Laboratories Inc | Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster |
JPH085779B2 (ja) * | 1989-09-22 | 1996-01-24 | 杏林製薬株式会社 | フレロキサシン点眼液 |
EP0425443A1 (de) * | 1989-10-27 | 1991-05-02 | Ciba-Geigy Ag | Injizierbares parasitizides Mittel |
CA2072366C (en) * | 1989-12-29 | 2002-08-20 | Laman A. Al-Razzak | Carboxylic acid-metal ion-acid complexes |
-
1992
- 1992-10-27 US US07/966,998 patent/US5290794A/en not_active Expired - Fee Related
-
1993
- 1993-09-29 CA CA002144652A patent/CA2144652A1/en not_active Abandoned
- 1993-09-29 DE DE69322405T patent/DE69322405T2/de not_active Expired - Fee Related
- 1993-09-29 AU AU52937/93A patent/AU670838B2/en not_active Ceased
- 1993-09-29 WO PCT/US1993/009252 patent/WO1994009779A1/en active IP Right Grant
- 1993-09-29 NZ NZ256962A patent/NZ256962A/en unknown
- 1993-09-29 SG SG1996005004A patent/SG46482A1/en unknown
- 1993-09-29 AT AT93923156T patent/ATE173925T1/de not_active IP Right Cessation
- 1993-09-29 EP EP93923156A patent/EP0666743B1/de not_active Expired - Lifetime
- 1993-09-29 ES ES93923156T patent/ES2124797T3/es not_active Expired - Lifetime
- 1993-09-29 DK DK93923156T patent/DK0666743T3/da active
- 1993-09-29 JP JP6511062A patent/JPH08504190A/ja active Pending
- 1993-10-11 MX MX9306321A patent/MX9306321A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5293793A (en) | 1994-05-24 |
MX9306321A (es) | 1994-04-29 |
DE69322405T2 (de) | 1999-04-29 |
JPH08504190A (ja) | 1996-05-07 |
AU670838B2 (en) | 1996-08-01 |
EP0666743A1 (de) | 1995-08-16 |
WO1994009779A1 (en) | 1994-05-11 |
EP0666743B1 (de) | 1998-12-02 |
DE69322405D1 (de) | 1999-01-14 |
DK0666743T3 (da) | 1999-08-16 |
SG46482A1 (en) | 1998-02-20 |
US5290794A (en) | 1994-03-01 |
ES2124797T3 (es) | 1999-02-16 |
NZ256962A (en) | 1996-08-27 |
CA2144652A1 (en) | 1994-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE168560T1 (de) | Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins | |
KR920002144A (ko) | 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제 | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
ATE237330T1 (de) | Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung | |
RS20090086A (en) | Nucleoside analogs with carobxamidine modified monocyclic base | |
MY117109A (en) | Injectable quinolone formulations. | |
AU1189688A (en) | Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states | |
IL96776A (en) | Antibacterial compositions containing quinolone carboxylic acid-metal ion-acid complexes | |
NO20000446L (no) | Anvendelse av fysiologisk akseptable vanadiumforbindelser, - salter og -komplekser | |
AU3245489A (en) | Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer | |
ATE173925T1 (de) | Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen | |
BR0114389A (pt) | Terapia antitumor que inclui derivado de distamicina | |
FR2794976B1 (fr) | Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane | |
EP0799618A3 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
TR200401810T4 (tr) | Kısırlık tedavisinde fsh'ın kullanılması | |
DK0711163T3 (da) | Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF | |
RU96104062A (ru) | Средство "витадерм" в комплексной терапии ожоговых ран | |
UA12937A (uk) | Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом | |
EP0621789A4 (en) | Pharmaceutical pentapeptide compositions and methods of use thereof. | |
SE9203296D0 (sv) | The use of inositoltrisphate for the preparing of medicaments | |
YU61302A (sh) | Analozi nukleozida sa modifikovanom karboksamidinskom bicikličnom bazom | |
MX9706759A (es) | Uso de penciclovir para el tratamiento de virus deherpes 8 humano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |